Serial Number | 97453092 |
Word Mark | GLYSTALI |
Filing Date | Friday, June 10, 2022 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Monday, June 24, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 30, 2023 |
Goods and Services | Anti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations for the treatment and prevention of eye diseases and conditions; Pharmaceutical preparations for the treatment and prevention of heart rhythm disorders; Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of hypertension; Pharmaceutical preparations for the treatment and prevention of skin disorders; Pharmaceutical preparations for the treatment and prevention of cancer and tumors; Pharmaceutical preparations for the treatment and prevention of allergies; Pharmaceutical preparations for the treatment and prevention of bone diseases; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and asthma; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, June 23, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Zydus Pharmaceuticals (USA) Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Pennington, NJ 08534 |
Party Name | Zydus Pharmaceuticals (USA) Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Pennington, NJ 08534 |
Event Date | Event Description |
Tuesday, June 14, 2022 | NEW APPLICATION ENTERED |
Thursday, June 23, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, February 15, 2023 | ASSIGNED TO EXAMINER |
Tuesday, February 21, 2023 | NON-FINAL ACTION WRITTEN |
Tuesday, February 21, 2023 | NON-FINAL ACTION E-MAILED |
Tuesday, February 21, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, April 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, April 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Saturday, April 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, April 24, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, May 30, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, May 10, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 30, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Monday, December 18, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, July 25, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Monday, December 18, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Monday, December 18, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, June 24, 2024 | SOU TEAS EXTENSION RECEIVED |
Monday, June 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, June 24, 2024 | SOU EXTENSION 2 FILED |
Monday, June 24, 2024 | SOU EXTENSION 2 GRANTED |
Thursday, December 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, December 18, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, December 19, 2023 | SOU TEAS EXTENSION RECEIVED |
Tuesday, December 19, 2023 | SOU EXTENSION 1 FILED |
Tuesday, December 19, 2023 | SOU EXTENSION 1 GRANTED |